We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Giving Immunotherapies the Green Light to Attack

News   Apr 05, 2017 | Original story from UNC Lineberger Comprehensive Cancer Center

 
Giving Immunotherapies the Green Light to Attack

T-cells. Credit: Zappys Technology Flickr

 
 
 

RELATED ARTICLES

Clinical Trial of Antiviral Drug To Treat Coronavirus Begins

News

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha.

READ MORE

Too Much of a Good Thing May Lead to Too Much of a Liver

News

A team of scientists suggest prolonged exposure to NRF2 and KEAP1 may contribute to enlargement of the liver and fatty liver diseases.

READ MORE

Antibody Equals Antidepressant?

News

Researchers have discovered that the level of NMDA receptor autoantibodies in the blood can increase with chronic stress, potentially acting as a self-produced antidepressant.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE